… were not observed in 20 patients with other tumor phenotypes. … , but patients with ER-PgR-
tumors had a significantly shorter survival from time of initial endocrine treatment than patients …

… The ER+PR+ combination, which was associated with low FIGO stages (P = 0.012) and
low tumor grade (P = 0.046), showed a superior course of patients' overall survival compared …

… patients fail to respond [l, 21. At present it is still controversial whether data about progesterone
… activity for estradiol and progesterone. From the scarce data in the literature it becomes …

… on the estrogen receptor (ER), progesterone … patient survival has produced controversial
results. Some studies have shown that receptor discordance is associated with poorer survival (…

… survival advantage was found in the stage I and II patients who … , estrogen receptor status,
and progestin receptor status, … Estradiol and progesterone receptor as prognostic factors in …

… between OS and ER presence was found only in patients with more than three involved
nodes (p = 0.04; fig. 1); in all other 7 subgroups of patients survival curves did not differ. …

… The survival of the patients was significantly (P < 0.0001) dependent on the stage of the …
the best survival for stage I disease and the worst survival for stage IV disease. The 158 patients …

… of estrogen to its receptor and bring about significant improvement in survival for the vast
majority of patients with estrogen … led to improved survival in many of the patients. However, the …

… whether changes in relative expression levels of progesterone receptor (PR) isoforms A and
… progesterone action. Their presence in breast tumors is used to predict functional estrogen …

… Objective: To examine the patterns of estrogen receptor (ER) and progesterone receptor (PR) …
We also assessed the disease-free survival (DFS) and overall survival (OS) in women with …